Jun Bao
Directeur Général chez IMPACT Therapeutics, Inc.
Fortune : 6 826 $ au 31/05/2024
Postes actifs de Jun Bao
Sociétés | Poste | Début | Fin |
---|---|---|---|
BiTech Pharma, Inc.
BiTech Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services BiTech Pharma, Inc. develops medicines. The private company is based in Emeryville, CA. Xiang Wu Ye has been the CEO of the company since 2008. | Président | 03/07/2009 | - |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Directeur Général | 01/09/2018 | - |
President | 01/09/2018 | - |
Historique de carrière de Jun Bao
Anciens postes connus de Jun Bao
Sociétés | Poste | Début | Fin |
---|---|---|---|
TRANSCENTA HOLDING LIMITED | Directeur/Membre du Conseil | 14/09/2021 | 23/08/2023 |
Independent Dir/Board Member | 14/09/2021 | 23/08/2023 | |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 01/07/2017 | 01/10/2019 |
Corporate Officer/Principal | 01/05/2013 | 01/09/2018 | |
Glaxosmithkline China Ltd. | Corporate Officer/Principal | 01/10/2010 | 01/05/2013 |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01/01/2005 | 01/01/2006 |
CTI BIOPHARMA CORP. | Corporate Officer/Principal | 01/10/2001 | 01/02/2005 |
PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | 01/07/1999 | 01/09/2001 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01/01/2006 | - |
Formation de Jun Bao
Shandong University | Undergraduate Degree |
University of Kansas | Doctorate Degree |
The University of Chicago | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 8 |
Chine | 5 |
Îles Cayman | 2 |
Opérationnelle
Corporate Officer/Principal | 6 |
Director/Board Member | 2 |
Chairman | 1 |
Sectorielle
Health Technology | 7 |
Consumer Services | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
TRANSCENTA HOLDING LIMITED | Health Technology |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
Entreprise privées | 7 |
---|---|
BiTech Pharma, Inc.
BiTech Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services BiTech Pharma, Inc. develops medicines. The private company is based in Emeryville, CA. Xiang Wu Ye has been the CEO of the company since 2008. | Commercial Services |
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
IMPACT Therapeutics, Inc.
IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Health Technology |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
Glaxosmithkline China Ltd. |